IIUM Repository

Sustained blood pressure reduction with chronic 1,2,3,4- tetrahydroisoquinolines administration in young adult, spontaneously hypertensive rats

Abdullah, Aszrin and Mohd. Shah, Azarisman and Abdul Razak, Tariq and Mohd Noor, Noriah (2011) Sustained blood pressure reduction with chronic 1,2,3,4- tetrahydroisoquinolines administration in young adult, spontaneously hypertensive rats. In: The 8th Annual Scientific Meeting, Malaysian Society of Hypertension, 14-16 January 2011, Kuala Lumpur.

Restricted to Repository staff only

Download (78kB) | Request a copy
Official URL: http:// www.msh.my


Background: Adrenaline plays a role in the pathogenesis of essential hypertension through excessive stimulation of the adrenomedullary hormonal system. Pharmacological inhibition of the adrenomedullary hormonal system should result in chronic, sustained blood pressure (BP) reduction. Objective: To study the effect of adrenaline synthesis enzyme (phenylethanolamine N-methyltransferase (PNMT)) inhibitor on blood pressure of young adult spontaneously hypertensive rats (SHRs), by utilising 1,2,3,4-tetrahydroisoquinolines (THIQ). Methods: 14 young adult male and female SHRs weighing between 160 and 270g were studied. 8 study rats administered intraperitoneally with daily THIQ (Treated) and 6 age-matched controls (Control) were included. Indirect systolic blood pressure (SBP) was measured by tail cuff method prior to drug study (baseline), 2-hours post-administration on D1, D7 and D14. Results: The mean baseline SBP in Treated and Control SHRs were 172.79 + 15.61 vs 171.69 + 17.27 mmHg respectively (p=1.00). The mean SBP at D1 were 143.00 + 32.43 vs 171.69 + 17.27 mmHg respectively (p=0.02). The mean SBP at D7 were 131.83 + 28.42 vs 173.06 + 19.62 mmHg respectively (p=0.03). The mean SBP at D14 were 152.42 + 24.96 vs 180.08 + 14.59 mmHg respectively (p=0.04). There were no significant differences in plasma catecholamine levels of control SHR group observed after 2-weeks. All treated SHR plasma catecholamine levels dropped 2-weeks following the PNMTI administration. However, the differences in catecholamine levels before and after treatment were only statistically significant in the group’s plasma adrenaline levels (p= 0.04). Comparison between groups showed the treated group’s plasma adrenaline and NA show a reduced trend following treatment with PNMTI but the differences were not statistically significant. Plasma dopamine levels of the group treated with PNMTI were significantly different (p= 0.01) compared to the control group. There was no significant difference in the mean weight of the two groups throughout the study duration. Conclusion: Chronic 1,2,3,4-tetrahydroisoquinolines administration is an effective inhibitor of PNMT, the enzyme that catalyzes the terminal step in adrenaline biosynthesis, thereby resulting in susta

Item Type: Conference or Workshop Item (Poster)
Additional Information: 3960/10282
Uncontrolled Keywords: blood pressure, adrenaline,PNMT, THIQ
Subjects: R Medicine > R Medicine (General)
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): Kulliyyah of Medicine > Department of Internal Medicine
Kulliyyah of Pharmacy > Department of Basic Medical Sciences
Kulliyyah of Medicine > Department of Basic Medical
Depositing User: Prof Noriah Mohd Noor
Date Deposited: 23 Feb 2012 11:08
Last Modified: 23 Feb 2012 16:12
URI: http://irep.iium.edu.my/id/eprint/10282

Actions (login required)

View Item View Item


Downloads per month over past year